Research Archives - Page 10 of 20 - Canadian Alopecia Areata Foundation

Epigallocatechin-3 Gallate as a Potential Alternative to JAK Inhibitors?

Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients For several years, the big breakthrough in Alopecia Areata research has

canaaf2021-11-27T14:57:25+00:00July 2nd, 2020|Research|

Concert Pharmaceuticals Releases Additional Data From Phase 2 Clinical Trial of CTP-543 In Alopecia Areata

In phase 2 of their clinical trial testing the drug CTP-543 (a JAK 1 and JAK 2 inhibitor) as a treatment for

canaaf2021-11-27T14:58:00+00:00June 17th, 2020|Clinical Trials, Research|

The Role of Lymphocytes in the Development and Treatment of Alopecia Areata

As we know, Alopecia Areata is disease where the person’s own immune system attacks their hair follicles. This self-attack is known as

canaaf2021-11-27T14:58:13+00:00June 5th, 2020|Research|